Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study

BACKGROUND: Since direct-acting antivirals (DAAs) have been approved for the treatment of hepatitis C virus (HCV) infection, a small series of patients with new-onset neuropsychiatric alterations have been referred to us. We therefore set out to study neuropsychiatric function in relation to DAAs pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Gastroenterol
Main Authors: Volpato, Sofia, Montagnese, Sara, Zanetto, Alberto, Turco, Matteo, De Rui, Michele, Ferrarese, Alberto, Amodio, Piero, Germani, Giacomo, Senzolo, Marco, Gambato, Martina, Russo, Francesco Paolo, Burra, Patrizia
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Hepatology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5759705/
https://ncbi.nlm.nih.gov/pubmed/29333276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2017-000183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados